Harrow IncHROW
Price$30.61

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $275.6M+38.1% YoYTTM through 30 Jun 2026
Net Income -$37.2MTTM through 30 Jun 2026
Free Cash Flow $5MTTM through 30 Jun 2026

Margins

Current
Gross Margin61.2%
EBITDA Margin-0.5%
Operating Margin-1.0%
Net Margin-13.5%

Returns

-244.9%ROE
-8.9%ROA

Balance Sheet Health

Debt / Equity10.28x
Current Ratio2.24x
Net Debt$197.4M
Cash & Equivalents$83.9M

Quality Metrics

Altman Z-Score2.26
Piotroski F-Score3 / 9
FCF Margin1.8%
Rule of 4029.1
Earnings-Beat Rate66.7%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $272.3M
Diluted EPS-$0.99TTM
'18'19'20'22'23'24'25
FY2025: $-0.14

Dividend

No dividend

Capital Allocation

R&D Spend$29M
Capex Intensity0.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.